Organizational Capabilities and Competitive Analysis

Today is the first day of class for our BeST program in the rabbit year, if we consider the starting of a year based on lunar calender. After a week of Chinese New Year celebration, all of us had to bid farewell to holiday and focused on the very last month of lecture classes under the BeST program.

Organizational Capabilities and Competitive Analysis. This is the topic of the day. Assoc. Prof. Dr Dewi Amat Sapuan and Assoc. Prof. Dr. M. Shanmugam started the lecture by introducing five organization's resources: financial, physical, human capital, technological and reputational. Regardless of the type of resources, the major factor of succeeding in the market is organizational capabilities, which is the ability to bring a product in the market faster than its competitors by integrating each individual resources to create competitive advantage. Competitive advantage is vital for a firm in order to outperform its competitors because the implementation of value-creating strategy allows sustainability of a firm in the market in the long run.

We also learned the Porter's Five Forces Model, which permits us to understand where the strength of a firm lies in the business situation. This learning is particularly useful to us whose going to be entrepreneurs in near future as it stimulates us to critically analyze the potential capabilities of a firm in a particular industry.

Throughout today's lecture, we gained insights on the importance of organizational capabilities and competitive advantages for a firm. Every lecture of this program is a building block for us to step nearer to be a successful entrepreneur. I am looking forward to participating in more exciting topics and activities...

Research Field Trip in Kuching, Sarawak

Finally, I have returned to my lovely home sweet home from Kuching. Last two weeks I have been to Kuching for a research trip under the supervision of my beloved lecturer Dr. Catherine Yule from Monash University, which refrained me from having the time to blog for two weeks. I need to conduct an experiment under a research project that entitled: 'Comparison of Phenolic Production in Ant Inhabited and Uninhabited Macaranga pruinosa trees in Peat Swamps'. The purpose of this project is to determine the production of phenolic compounds in plants inhabited by ants comparing them to uninhabited ones. Hence I need to fly to several national parks in Kuching, namely Bako, Kubah and Gunung Gading National parks to collect some samples.

It was a wonderful and memorable experience as it was my first field trip to forests, and I got the chance to see a real Rafflesia flower of 68 cm which had blossomed for 4 days.

We were so lucky to see one as it only blossom for a week after 9 months of maturation or the so-called 'pregnancy' period. Furthermore, we managed to see all sorts of exotic and endangered wildlife animals, such as gibbons, orang utans, bear cats, etc. The wonderful memories I had were indescribable. The lifestyle in Kuching is just so peaceful. It is just so different from the hustle-bustle city as in KL, a place where I stay for 23 years.

Now that I have returned home, back to KL, nevertheless I will treasure the wonderful memories of the life in Kuching. Hopefully I can go back to Kuching in near future.

As Chinese New Year is coming real soon, I was told by my lovely classmate Yassin that we were given one week holiday till 7th February. It shall be another wonderful memories as I will be celebrating this new year with my family, relatives and friends. Am looking forward for this festive season to come...

Clinical Data Management and Biostatisticians

In clinical research, a tool called clinical data management system (CDMS) is used to handle the data of a clinical trial. The data will be gathered from the investigator in case report form, which are then stored in the CDMS. Proper storage and good management of these data are vital in the pharmaceutical industry in order to provide high quality and reliability of the data results. The reason why quality is of essence in this industry is because poor quality will mean a postponement in the development of drug and introduction to the market, which will eventually bring about huge loss to the pharmaceutical companies.

For these reasons, the fifth session introduced us to clinical data management. Although I could not attend the session because I need to attend research field trip briefing at university, I took the initiative to study this topic by myself and obtained information online.

I learned that to produce quality clinical data management and to ensure process improvements, ongoing quality checks which draw attention to the probability of error estimation and error minimization should be carried out. Full commitment should be made by institutions and organizations when handling clinical data to ensure data are stored appropriately and suitably for later use. Nevertheless, this is not always the case as it could be relatively costly to do systematic curation as it not only involves carrying out good and reproducible science, but also about integrating the data from various sources and applying them in novel ways.

When reaches the end of the clinical trial, data collected in the CDMS has to be sent to the statisticians to analyze the data before sending to the regulatory authorities for approval. This is when biostatisticians come into the picture of clinical research. Biostatisticians play a significant role in phase I trial to permit clinical researchers to produce accurate inferences from acquired data and to deduce sound decisions when uncertainty is present. Statistical planning as well as analysis which are done with high accuracy will ensure that the reporting and documentations are delivered with high-quality. Because of the importance of biostatisticians in clinical research, guidelines by the Royal Statistical Society have been set up.

In a nutshell, the field of clinical research require cooperation from many parties and organizations to ensure a high-quality finishing result. I really glad I am part of this BeST programme which covers not only biotechnology field but clinical research field to provide insight in this rapidly expanding field, which will generate plenty of exciting opportunities for the trained professionals.

Clinical Research - A Potential Market in Malaysia

Clinical trials have been very crucial when it comes to research and development of new drugs and treatments. With Asia booming as the power house in pharmaceutical sector, it is of no surprise that Malaysian government is joining other Asian countries in tapping into this sector.

Malaysia is one of the countries in Asia which has everything to offer when it comes to pharmaceutical research and development, be it the clinical trials or the facilities. Yet, Malaysia seems to be bypassed by foreign investors due to the lack of publicity as well as some problems that happen in Malaysia, such as delayed timelines, bureaucracy, and long approval processes.

In order to succeed in this industry, BeST programme has incorporated clinical research into the technical module. The first two sessions were on IP and ethics. Moving on to the third day, the session got much more challenging and informative.

We studied the role of sponsors for clinical trials. The sponsors have to select for capable candidates as investigators. Application for licenses, quality control and quality assurance are also sponsor’s responsibilities to ensure that clinical protocols and designs are carried out with accordance to the standard procedures and to ensure that the produced results are reliable.

Next, we also were taught on good clinical practice (GCP). This is a crucial part under clinical trials because trials involve human patients. GCP plays a very crucial role in protecting the human subjects from being exploited. This is when informed consent comes into the picture, where each human participant has the right to decide whether or not to participate. Since informed consent is not a contract, participants have the right to withdraw from the trial at any time.

The session ended with the importance of safety reporting, which more specifically known as adverse event reporting. This reporting system is very important because it takes into account the ethical and legal responsibilities in obtaining and analyzing safety details. Furthermore, it permits effective communication of correct information to regulators, physicians as well as the consumers.

From the session, it was understood that healthcare and clinical research have great potential in Malaysia. It is enlightening that the government has taken extra measures to strengthen the human resource force by incorporating this session into BeST programme. It is time for the government to take prompt action to build up experience healthcare professionals. If no concrete steps are taken, we will lose out. It is time for us to sit tight, be bold and move forward.

Clinical Research and Ethics

Today lecture was on the introduction to clinical research and ethics. A speaker from Hospital Ampang, Dr. Sia Koon Ket, who is the Head of Clinical Research Centre has provided us with the definitions of different terms involving clinical research and ethics.

Biomedical research is an area of research which involves using human as experimental subjects. In order to test for the efficacies of drugs and medicines, there is a requirement for human experimentation. Hence there is a protocol which must be adhered to when conducting a clinical trial. We learned the four phases of clinical trials. Also, we learned about ethics of clinical research. This ethics issue is very vital in the case of biomedical research because it involves the potential exploitation or abuse of the human research subjects. Thus the issue of what is being ethical or unethical always persist in the research of drugs and medicines. A great example of human exploitation was the Nazi doctors, which exploited young children and prisoners. All these information were really useful for us in case we enter the biomedical research field.

Today's lecture gave an insight of the various issues of clinical research and ethics we are exposed to. An understanding of different points of view from all sides with the ability to make accurate judgement between morally right or wrong is hence vital to ensure clarity and transparency when conducting a trial in the present as well as in the future.

Intellectual Property - Patents, Copyrights, Trademarks

Intellectual property (IP) is the creations of one’s mind. It includes copyrights, patents, trademarks, industrial design rights and trade secrets. IP protection has been of critical importance in today’s modern world to encourage innovation. This is because IP protection allows ideas to be protected so that businesses would reap maximum benefits of their inventions and would encourage more research and development. Due to the importance of IP, BeST programme has arranged an experienced and reputable speaker Assoc. Prof. Rohazar Wati Zuallcobley from the Faculty of Law, MARA University of Technology, for us students.

She started her lecture by telling us the importance of strong IP for innovation in boosting the national economic growth, and that under the law of IP, exclusive rights of owners to intangible assets such as knowledge and creativity can be granted. We understood the differences between different types of IP, how IP plays a role as economic tools for conversion of innovation into assets, how patents are applied and granted and the several routes to grant a patent.

The second half of her lecture was on trademark as a branding strategy. The lecture became much more interesting when she taught us the ways to differentiate registrable and non-registrable trademarks, as well as the history and function of trademarks. Finally she concluded the lecture with confidential information and trade secret, which allowed us to understand the rationale and history behind them.

Before she ended her lecture, she reminded us on one thing that happens to today’s high-technology world: the digital revolution has made IP become more susceptible to mass copying and zero-cost distribution of digital materials. This will pose a threat to IP and hence each of us should help to fight against piracy and counterfeiting to help the inventors from suffering losses and getting full protection from IP system. May all Malaysians as well as people from other countries will cherish the hard work and creation of great minds.

Secret to Launch a Good Business Idea

Today, our beloved speaker Dr. Roland continued with his lecture on innovation and entrepreneurship. Before he started, he asked the class: ‘How are you?’ Most of us said ‘good’ or ‘fine’. He then said: ‘You all should have said I feel brand new, because it shows enthusiasm in towards your life. This positive attitude is very important to achieve success in either business or life’ He proceeded with the next question: ‘Are you ready?’ We replied with a yes. Again he said: ‘You all should have said I was born ready. This shows that you are really prepared for what is coming up next. Again this shows enthusiasm and positive attitude which all of you should have.’ This showed why I enjoy his lesson so much, because we always learn new things from him, even at the beginning of his lecture.

We started our lecture on discussing a case study named ‘Nothing Unique to Offer’. This case study involved a business man wanting to venture into a pizza business near a local university even when there are three existing competitors. After each group has presented their solution to the case study problem, he pointed out our good and bad points which have benefited everyone of us in order to practically apply the two concepts he taught yesterday, which were importance versus interesting and NABC approach (N = need, A = approach, B = benefits per costs, C = Competition/alternatives).

The lecture continued with more interactive sessions with the most interesting session being the ‘Elevator Pitch’. An ‘Elevator Pitch’ means a 30 to 60 seconds well-practiced and succinct description of our company that your mother or even your grandmother can understand during the time it would needed to ride up an elevator. It is something like the lyrics of Eminem’s ‘Lose Yourself’:

Look, if you had one shot…

One opportunity to seize everything you ever wanted…

One moment…

Would you capture it…

Or just let it slip away?

Why should an entrepreneur need to put great emphasis on ‘Elevator Pitch’? This is simply because it can help to figure out what is at the core of a person’s business. Dr. Roland continued with the three main components of Elevator Pitch: Hook à NABC à Close. Each group has to present its product with the aim to kill during Elevator Pitch. Some groups did really very good job and were praised by the speaker and the crowds.

Yesterday and today’s lectures were really very valuable as we learned to think and act like an entrepreneur. The lectures also encouraged us to allow our business idea juices to flow. Thank you Dr. Roland, for making the lectures interesting and inspiring. Kudos to you!